Used as a key intermediate in the synthesis of antidiabetic drugs, particularly in the development of dipeptidyl peptidase-4 (DPP-4) inhibitors. Its stereochemistry enables high selectivity and potency in targeting the enzyme, improving glucose control in type 2 diabetes. The compound’s structure supports strong binding affinity and metabolic stability, making it valuable in oral hypoglycemic agents. It is also explored for enhancing pharmacokinetic properties in related therapeutic candidates.